Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors

This study has been completed.
Sponsor:
Information provided by:
Ziopharm
ClinicalTrials.gov Identifier:
NCT00608803
First received: January 22, 2008
Last updated: September 16, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)